Page 2 - Sofinnova Partner News Today

Moon Surgical announced today that it successfully completed 30 first-in-human laparoscopy procedures with its Maestro surgical robot.

Investegate announcements from Moon Surgical, Moon Surgical Receives FDA 510(k) Clearance

The company's unique Maestro System is designed to augment the surgeon at the bedside in minimally invasive soft tissue surgical proceduresPARIS and SAN FRANCISCO / ACCESSWIRE / December 6, 2022 / Moon

Investegate announcements from Moon Surgical, Moon Surgical Mark Toland Independent Board Member

PARIS, FRANCE and SAN FRANCISCO, CA / ACCESSWIRE / November 15, 2022 / Moon Surgical, a pioneer in collaborative robotics, today announced the appointment of Mark Toland as an independent board member.

MILAN, ITALY / ACCESSWIRE / August 10, 2022 / Nephris, a biotech company developing first-in-class therapies for chronic kidney diseases, extends its congratulations to the researchers from the Romeo and

DGAP-News: Sofinnova Partners / Key word(s): Personnel Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer 30.06.2022 / 08:00 The issuer is solely responsible for the content of this announcement. AAVantgarde Announces t...

The Series A funding will enable completion of the development of the company's unique co-manipulative surgical robotic product and prepare it for a successful commercial launch.PARIS, FRANCE and SAN FRANCISCO

Moon Surgical raised $31.3 million in Series A funding to expand its team and accelerate its Maestro robotic surgery system's development.

Press release content from Accesswire. The AP news staff was not involved in its creation.